These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 37330043)

  • 1. IL-33's role in the gut immune system: A comprehensive review of its crosstalk and regulation.
    Kaur H; Kaur G; Ali SA
    Life Sci; 2023 Aug; 327():121868. PubMed ID: 37330043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine.
    Cayrol C; Girard JP
    Cytokine; 2022 Aug; 156():155891. PubMed ID: 35640416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease.
    Andoh A; Nishida A
    J Gastroenterol; 2023 Feb; 58(2):69-78. PubMed ID: 36376594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-33 Alarmin and Its Active Proinflammatory Fragments Are Released in Small Intestine in Celiac Disease.
    Perez F; Ruera CN; Miculan E; Carasi P; Dubois-Camacho K; Garbi L; Guzman L; Hermoso MA; Chirdo FG
    Front Immunol; 2020; 11():581445. PubMed ID: 33133101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammation.
    Pastorelli L; De Salvo C; Cominelli MA; Vecchi M; Pizarro TT
    Therap Adv Gastroenterol; 2011 Sep; 4(5):311-23. PubMed ID: 21922030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.
    Cayrol C; Girard JP
    Immunol Rev; 2018 Jan; 281(1):154-168. PubMed ID: 29247993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-33 controls IL-22-dependent antibacterial defense by modulating the microbiota.
    Röwekamp I; Maschirow L; Rabes A; Fiocca Vernengo F; Hamann L; Heinz GA; Mashreghi MF; Caesar S; Milek M; Fagundes Fonseca AC; Wienhold SM; Nouailles G; Yao L; Mousavi S; Bruder D; Boehme JD; Puzianowska-Kuznicka M; Beule D; Witzenrath M; ; Löhning M; Klose CSN; Heimesaat MM; Diefenbach A; Opitz B
    Proc Natl Acad Sci U S A; 2024 May; 121(22):e2310864121. PubMed ID: 38781213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of interleukin-33 in innate-type immune cells in allergy.
    Nakae S; Morita H; Ohno T; Arae K; Matsumoto K; Saito H
    Allergol Int; 2013 Mar; 62(1):13-20. PubMed ID: 23439054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-33 and ST2 Signaling in Tumor Microenvironment.
    Hong J; Kim S; Lin PC
    J Interferon Cytokine Res; 2019 Jan; 39(1):61-71. PubMed ID: 30256696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-33/ST2 axis in inflammation and immunopathology.
    Milovanovic M; Volarevic V; Radosavljevic G; Jovanovic I; Pejnovic N; Arsenijevic N; Lukic ML
    Immunol Res; 2012 Apr; 52(1-2):89-99. PubMed ID: 22392053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cells are essential intermediaries in regulating IL-33/ST2 signaling for an immune network favorable to mucosal healing in experimentally inflamed colons.
    He Z; Song J; Hua J; Yang M; Ma Y; Yu T; Feng J; Liu B; Wang X; Li Y; Li J
    Cell Death Dis; 2018 Dec; 9(12):1173. PubMed ID: 30518915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-33 and the intestine: The good, the bad, and the inflammatory.
    Hodzic Z; Schill EM; Bolock AM; Good M
    Cytokine; 2017 Dec; 100():1-10. PubMed ID: 28687373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis.
    Lopetuso LR; Scaldaferri F; Pizarro TT
    Fibrogenesis Tissue Repair; 2012 Oct; 5(1):18. PubMed ID: 23062310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL33: Roles in Allergic Inflammation and Therapeutic Perspectives.
    Chan BCL; Lam CWK; Tam LS; Wong CK
    Front Immunol; 2019; 10():364. PubMed ID: 30886621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases.
    Chen WY; Tsai TH; Yang JL; Li LC
    Cell Physiol Biochem; 2018; 49(1):349-358. PubMed ID: 30138941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders.
    Saluja R; Ketelaar ME; Hawro T; Church MK; Maurer M; Nawijn MC
    Mol Immunol; 2015 Jan; 63(1):80-5. PubMed ID: 25017307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-33 Receptor-Expressing Regulatory T Cells Are Highly Activated, Th2 Biased and Suppress CD4 T Cell Proliferation through IL-10 and TGFβ Release.
    Siede J; Fröhlich A; Datsi A; Hegazy AN; Varga DV; Holecska V; Saito H; Nakae S; Löhning M
    PLoS One; 2016; 11(8):e0161507. PubMed ID: 27548066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of T
    Brockmann L; Giannou AD; Gagliani N; Huber S
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of type 2 immunity in intestinal inflammation.
    Bamias G; Cominelli F
    Curr Opin Gastroenterol; 2015 Nov; 31(6):471-6. PubMed ID: 26376478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.